afford567,
I understand your point well and agree that this could be possible. I also believe that there is enough integrity involved from who the investigators are to see one or more resign if they felt NWBO was trying to cover something up. My main point with agreeing with austinmediainc was that there are at least 2 investigations going on with regard to NWBO and one or both should have had something to report by now unless they were asked not to. Mr. Woodford would have reported on behalf of his investors and NWBO on behalf of theirs. This seems quite apparent. The fact that this has not happened in the face of deep losses over an extended period of time indicates that there may be something much bigger going on. The evidence continues to roll in that DC therapy and checkpoint inhibitors in combination hold great promise. NWBO's combination therapy patent, therefore, holds great value. The stakes at this point could not be too much higher since the Phase 3 trial has a planned ending in September and August marks the one year anniversary of the screening hold. This is an "all in" moment for both sides and that means winner takes all soon if an agreement is not announced soon. The agreement tease appears to be a backup plan for big pharma if NWBO can't be squeezed out before something big is announced. This creates the kind of tension we are currently witnessing. Keep September in your sights even if something should happen sooner. I believe this is the tension stretch period. Best wishes.
News 
Market Data 
Discover 
